Index by author

September 01, 2004; Volume 71,Issue 9

  1. Bray, George A.

    1. TheDASHdiet for high blood pressure: From clinical trial to dinner table
      Njeri Karanja, PhD, T.P. Erlinger, MD, MPH, Lin Pao-Hwa, PhD, Edgar R. Miller, MD, PhD and George A. Bray, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 745-753;

      Eating right lowers blood pressure by about as much as any single antihypertensive drug—but will patients do it?

  2. Burke, Carol A.

    1. A 48-year-old woman with nausea, vomiting, early satiety, and weight loss
      James K. Stoller, MD, Mohammed A. Qadeer, MD and Carol A. Burke, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 693-712;

      She has lost 20 pounds in the last 1 1/2 years. What is the cause, and what is the treatment?

  3. Clough, John D.

    1. A DASH of prevention
      John D. Clough, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 682;

      The DASH diet is clearly a useful tool for lowering blood pressure in dedicated patients.

  4. Erlinger, T.P.

    1. TheDASHdiet for high blood pressure: From clinical trial to dinner table
      Njeri Karanja, PhD, T.P. Erlinger, MD, MPH, Lin Pao-Hwa, PhD, Edgar R. Miller, MD, PhD and George A. Bray, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 745-753;

      Eating right lowers blood pressure by about as much as any single antihypertensive drug—but will patients do it?

  5. Haynes, William G.

    1. Homocysteine: Is it a clinically important cardiovascular risk factor?
      Steven R. Lentz, MD, PhD and William G. Haynes, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 729-734;

      The jury is still out as to whether homocysteine is a cause, consequence, or marker of cardiovascular disease. B vitamins lower homocysteine levels; whether they reduce risk is also unknown, but they are cheap and safe.

  6. Hoogwerf, Byron J.

    1. A DASH-like diet can decrease cardiovascular risk, but barriers to implementation exist
      Byron J. Hoogwerf, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 755-756;

      Making dietary changes and sticking to them is necessary but difficult.

  7. Karanja, Njeri

    1. TheDASHdiet for high blood pressure: From clinical trial to dinner table
      Njeri Karanja, PhD, T.P. Erlinger, MD, MPH, Lin Pao-Hwa, PhD, Edgar R. Miller, MD, PhD and George A. Bray, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 745-753;

      Eating right lowers blood pressure by about as much as any single antihypertensive drug—but will patients do it?

  8. Lentz, Steven R.

    1. Homocysteine: Is it a clinically important cardiovascular risk factor?
      Steven R. Lentz, MD, PhD and William G. Haynes, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 729-734;

      The jury is still out as to whether homocysteine is a cause, consequence, or marker of cardiovascular disease. B vitamins lower homocysteine levels; whether they reduce risk is also unknown, but they are cheap and safe.

  9. Martins, David

    1. Hypertension treatment in African Americans: Physiology is less important than sociology
      David Martins, MD and Keith Norris, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 735-743;

      Social, cultural, and economic barriers to care are probably more important than any true physiologic differences between races.

  10. Miller, Edgar R.

    1. TheDASHdiet for high blood pressure: From clinical trial to dinner table
      Njeri Karanja, PhD, T.P. Erlinger, MD, MPH, Lin Pao-Hwa, PhD, Edgar R. Miller, MD, PhD and George A. Bray, MD
      Cleveland Clinic Journal of Medicine September 2004, 71 (9) 745-753;

      Eating right lowers blood pressure by about as much as any single antihypertensive drug—but will patients do it?

« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue